G-protein coupled receptors (GPCRs) represent important targets for drug discovery because they participate in a wide range of cellular signalling pathways that play a role in a variety of pathological conditions. The characterization of the patho-physiological profile and functional roles of new receptors is highly dependent on the availability of potent and selective ligands and new screening assays. The study of the pharmacological profile of new chemical entities is very important in order to predict the activity of drugs and their clinical adverse effect in humans. In the last decade, a large number of new in vitro radiolabel-free assays were developed and relevant information on diseases was upgraded. In particular, radiolabel-free assays led significant easy to handle and safer tools for operators. The aim of this review is to analyze these assays in terms of new drug activity and toxicology prediction and translation of non-clinical findings to humans in order to provide a powerful tool to aid drug development.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/1389557516666160808120207 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of a Testing Funnel for Identification of Small-Molecule Modulators Targeting Secretin Receptors.
SLAS Discov
January 2021
Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
The secretin receptor (SCTR), a prototypical class B G protein-coupled receptor (GPCR), exerts its effects mainly by activating Gαs proteins upon binding of its endogenous peptide ligand secretin. SCTRs can be found in a variety of tissues and organs across species, including the pancreas, stomach, liver, heart, lung, colon, kidney, and brain. Beyond that, modulation of SCTR-mediated signaling has therapeutic potential for the treatment of multiple diseases, such as heart failure, obesity, and diabetes.
View Article and Find Full Text PDFLigand binding kinetics at histamine H receptors by fluorescence-polarization with real-time monitoring.
Eur J Pharmacol
April 2019
Heinrich Heine University Düsseldorf, Institute of Pharmaceutical and Medicinal Chemistry, Universitaetsstr. 1, 40225 Duesseldorf, Germany. Electronic address:
Growing evidence recommends incorporating the concept of drug-target residence times within drug development and screening programs. For many targets, systematic research for binding kinetics is emerging and reported, as in case of the histamine H receptor. Alternatively, fluorescent methods based on Foerster resonance energy transfer have been reported recently but application of fluorescence polarization to kinetics of unlabeled ligands is not known to us.
View Article and Find Full Text PDFLigation-Based qPCR-Amplification Assay for Radiolabel-Free Detection of ATP and NAD with High Selectivity and Sensitivity.
Anal Chem
January 2019
College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of the Ministry of Education, The Institute for Advanced Studies, Hubei Province Key Laboratory of Allergy and Immunology , Wuhan University, Wuhan , Hubei 430072 , PR China.
We have developed a new sensing system based on quantitative real-time polymerase chain reaction assay (qPCR) to detect adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide (NAD) with high sensitivity and selectivity. T4 DNA ligase can catalyze the ligation of two short oligonucleotides (DNA1 and DNA2), which complement a template (cDNA), in the presence of its cofactor, ATP, resulting in increased template concentration and decreased Ct values in qPCR assays. Similarly, the Escherichia coli DNA ligase is also able to catalyze the ligation of DNA1 and DNA2 upon the addition of NAD.
View Article and Find Full Text PDFFluorescence-based assay for accurate measurement of transcriptional activity in trypanosomatid parasites.
Cytometry A
July 2018
Laboratório de Regulação da Expressão Gênica, Instituto Carlos Chagas, FIOCRUZ, Paraná, Brazil.
Trypanosomatid parasites are causative agents of neglected human diseases. Their lineage diverged early from the common eukaryotic ancestor, and they evolved singular mechanisms of gene expression that are crucial for their survival. Studies on unusual and essential molecular pathways lead to new drug targets.
View Article and Find Full Text PDFsCLIP-an integrated platform to study RNA-protein interactomes in biomedical research: identification of CSTF2tau in alternative processing of small nuclear RNAs.
Nucleic Acids Res
June 2017
Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Germany.
RNA-binding proteins (RBPs) are central for gene expression by controlling the RNA fate from birth to decay. Various disorders arising from perturbations of RNA-protein interactions document their critical function. However, deciphering their function is complex, limiting the general functional elucidation of this growing class of proteins and their contribution to (patho)physiology.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!